Advertisement
Advertisement
Ghana News

FDA vows to prosecute salt manufacturers who fail to regularise operations

Advertisement

The Food and Drug Administration (FDA) has warned that it will punish artisanal salt groups and large-scale salt makers who fail to register their activities with the agency.

The FDA stated that the warning is intended to avoid iron deficiency anaemia, which can result in stillbirths, congenital abnormalities, lower cognitive ability, infant mortality, delayed physical development, and goitre in both humans and animals.

Advertisement

The FDA highlighted that the failure to iodize edible salt as required by law is a grave infraction and a substantial public health risk.

The FDA sent a letter to artisanal salt producer groups and producers, large-scale salt makers, salt storage facility operators, salt transporters, and merchants on January 23, 2024, stating, “The public is hereby cautioned that those who violate the provisions of salt iodisation in Act 851 will be prosecuted.”

The FDA further advised that salt for industrial use should not be carried unless authorized by a permit issued by the Authority.

“It must further be noted that Section 107(6)(c) of Act 851 prescribes that salt for industrial purposes should not be transported unless it is covered by a permit issued by the Authority. It is also mandatory under Section 97 of Act 851 for all packaged salt to be registered before being put on the market or displayed or offered for sale,” the FDA stressed.

Read the notice below:

https://citinewsroom.com/wp-content/uploads/2024/01/NOTICE-TO-ARTISANAL-SALT-MINER-LARGE-SCALE-1.pdf

Advertisement
Advertisement

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker!